Tiger Fitness
Well-known member
Author
- Joined
- Sep 12, 2021
- Messages
- 873
- Points
- 28
Mark Lobliner explains why testosterone replacement therapy is widely misunderstood and why low testosterone poses a far greater health risk than medically supervised TRT.
He breaks down a key point early. You cannot “abuse” TRT. Once testosterone goes beyond prescribed, physiological levels, it is no longer TRT. It becomes a steroid cycle. Medically supervised TRT only restores testosterone to normal ranges.
Lobliner explains that testosterone itself does not increase mortality risk. Low testosterone does. Research consistently links low testosterone to higher all-cause mortality, worse metabolic health, and increased cardiovascular disease. Men with chronically low testosterone face a 30 to 40 percent higher risk of early death.
The video outlines how testosterone affects the entire body, not just muscle or libido. Normal levels help maintain muscle mass, regulate fat storage, protect bone density, improve insulin sensitivity, and reduce systemic inflammation. When testosterone stays low, these systems decline together, driving obesity, diabetes, heart disease, and reduced quality of life.
Lobliner cites large observational studies and randomized controlled trials showing that TRT, when prescribed and monitored, does not increase heart attack, stroke, or cardiovascular death risk. In many cases, men whose testosterone levels are normalized show better survival outcomes than untreated men with low testosterone.
He also stresses the importance of medical oversight. Self-administering excessive doses and calling it TRT is misleading and dangerous. Proper TRT is hormone normalization, not enhancement.
The core message is clear. Ignoring low testosterone is not a neutral decision. For men with a true deficiency, treating it can improve health span, energy, body composition, and long-term outcomes.
He breaks down a key point early. You cannot “abuse” TRT. Once testosterone goes beyond prescribed, physiological levels, it is no longer TRT. It becomes a steroid cycle. Medically supervised TRT only restores testosterone to normal ranges.
Lobliner explains that testosterone itself does not increase mortality risk. Low testosterone does. Research consistently links low testosterone to higher all-cause mortality, worse metabolic health, and increased cardiovascular disease. Men with chronically low testosterone face a 30 to 40 percent higher risk of early death.
The video outlines how testosterone affects the entire body, not just muscle or libido. Normal levels help maintain muscle mass, regulate fat storage, protect bone density, improve insulin sensitivity, and reduce systemic inflammation. When testosterone stays low, these systems decline together, driving obesity, diabetes, heart disease, and reduced quality of life.
Lobliner cites large observational studies and randomized controlled trials showing that TRT, when prescribed and monitored, does not increase heart attack, stroke, or cardiovascular death risk. In many cases, men whose testosterone levels are normalized show better survival outcomes than untreated men with low testosterone.
He also stresses the importance of medical oversight. Self-administering excessive doses and calling it TRT is misleading and dangerous. Proper TRT is hormone normalization, not enhancement.
The core message is clear. Ignoring low testosterone is not a neutral decision. For men with a true deficiency, treating it can improve health span, energy, body composition, and long-term outcomes.
